Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + Cytarabine in Newly Diagnosed CML
NCT00028847Phase 2Unknown
- Sponsor
- Commissie voor Klinisch Toegepast Onderzoek
- Start
- Apr 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of imatinib in chronic myeloid leukemia (CML), sponsored by Commissie voor Klinisch Toegepast Onderzoek. Status: unknown.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00028847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028847.